Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2430-2439

  Maurice, Madelon M ^a   Nakamura, Hajime ^b   Gringhuis, Sonja ^a   Okamoto, Takashi ^c   Yoshida, Shinichi ^c   Kullmann, Frank ^d   Lechner, Sandra ^d   Van Der Voort, Ellen A M ^a   Leow, Angela ^a   Versendaal, Johannes ^a   Muller Ladner, Ulf ^d   Yodoi, Junji ^b   Tak, Paul P ^a   Breedveld, Ferdinand C ^a   Verweij, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THIOREDOXIN REDUCTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; MEASUREMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; FIBROBLASTS; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033497717     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6     Document Type: Article

References (46)

1. Firestein GS, Zvaifler NJ. Rheumatoid arthritis: a disease of disordered immunity. In: Gallin J, Goldstein IM, Snyderman R, editors. Inflammation. 2nd ed. New York: Raven Press; 1992. p. 959-75.
2. Roberts NA. Free radicals, immunoglobulins and complement as mediators of inflammation. Baillieres Clin Rheumatol 1988;2:211-32.
3. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993;49:506-22.
4. Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995;51:419-36.
5. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995;54:505-10.
6. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, et al. Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 1994;153:4880-9.
7. Hartmann HJ, Gaertner A, Weser U. Copper-dependent control of the enzymic and phagocyte induced degradation of some biopolymers, a possible link to systemic inflammation. Clin Chim Acta 1985;152:95-103.
8. Schreck R, Albermann K, Baeuerle PA. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992;17:221-37.
9. 2 activates CD11b/CD18 dependent cell adhesion. Biochem Biophys Res Commun 1988;157:443-9.
10. 1-antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1991;50:915-6.
11. Heliövaara M, Knekt P, Aho K, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994;53:51-3.
12. 2-superoxide dismutase. Rheumatol Int 1994;14:119-26.
13. 2superoxide dismutase in murine model of acute and chronic inflammation. Inflammation 1993;17:595-611.
14. Kakimoto K, Kojima Y, Ishii K, Onoue K, Maeda H. The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice. Clin Exp Immunol 1993;94:241-6.
15. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
16. Nakamura H, Nakamura K, Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-69.
17. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989;264:13963-6.
18. Holmgren A. Thioredoxin. Annu Rev Biochem 1985;54:237-71.
19. Luthman M, Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 1982; 21;6628-33.
20. Sahaf B, Soderberg A, Spyrou G, Barral AM, Pekkari K, Holmgren A, et al. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp Cell Res 1997;236:181-92.
21. Sachi Y, Hirota K, Masutani H, Toda K, Takashi O, Takigawa M, et al. Induction of ADF/TRX by oxidative stress in keratinocytes and Iymphoid cells. Immunol Lett 1995;44:189-93.
22. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, et al. Adult T cell leukemia factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 1994;42:75-80.
23. Tomimoto H, Akiguchi I, Wakita H, Kimura J, Hori K, Yodoi J. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res 1993;625:1-8.
24. Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, et al. Cloning and expression of a cDNA for human thioredoxin. J Biol Chem 1988;263:15506-12.
25. Matthews JR, Wakasugi N, Virelizier J-L, Yodoi J, Hay RT. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 1992;20:3821-30.
26. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 1997;94:3633-8.
27. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. Activation of the transcription factor nuclear factor KB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-91.
28. Dooley S, Herlitzka I, Hanselmann R, Ermis A, Henn W, Remberger K, et al. Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppression gene nm23-H1 in rheumatoid arthritis. Ann Rheum Dis 1996;55:298-304.
29. Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG, Gay S. Spontaneous expression of immediate-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int 1992;12:53-9.
30. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, et al. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I-and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A 1990;87:8282-6.
31. Liang S-M, Lee N, Chen Y, Liang C-M. Effects of glutathione on the synthesis and turnover of interleukin-2 receptors. Cell Immunol 1992;144:131-42.
32. Schenk H, Vogt M, Droge W, Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J Immunol 1996;156: 765-71.
33. Nakamura H, DeRosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996;8:603-11.
34. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
35. Parker RH, Pearson CM. A simplified synovial biopsy needle. Arthritis Rheum 1963;6:172-6.
36. Hamann D, Baars PA, Hooibrink B, van Lier RAW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 1996;9:3513-21.
37. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJM, Kluin PM, et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995;38:1457-65.
38. Thurkow EW, van der Heijden IM, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared to patients with Yersinia-induced arthritis and osteoarthritis. J Pathol 1997;181:444-50.
39. Raap AK, van de Corput MPC, van Gijlswijk RAW, Tanke RPM, Wiegant J. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin-or fluorochrome tyramides. Hum Mol Genet 1995;4:529-34.
40. Sakurada S, Kato T, Okamoto T. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-L-cysteine and aspirin. Int Immunol 1996;8:1483-93.
41. Rozell B, Hansson HA. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 1985;38:79-86.
42. Kaghad M, Dessaprs F, Jacquemin-Sablon H, Caput D, Fradelize D, Wollman EE. Genomic cloning of human thioredoxin-encoding gene: mapping of the transcriptional start-point and analysis of the promoter. Gene 1994;140:272-8.
43. Taniguchi Y, Taniguchi-Ueda Y, Mori K, Yodoi J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T cell leukemia derived factor (ADF)/ human thioredoxin (TRX) gene. Nucleic Acids Res 1996;24: 2748-52.
44. Maurice MM, Nakamura H, van der Voort EAM, van Vliet AI, Staal FJT, Tak PP, et al. Evidence for a role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis, J Immunol 1997;158:1458-65.
45. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440.
46. Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill S, Kirkpatrick DL. The thioredoxin/thioredoxin reductase redox system and control of cell growth. Oncol Res 1994;6:539-44.